Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corium Intl (CORI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited...

CORI : 11.43 (+6.92%)
Corium International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 16, 2017 / Corium International, Inc. (NASDAQ: CORI) will be discussing their earnings results in their Q4 Earnings Call to be held on November 16, 2017 at 5:00 PM...

CORI : 11.43 (+6.92%)
Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the fourth quarter and fiscal year ended September 30, 2017 on Thursday, November 16, 2017 after the close...

CORI : 11.43 (+6.92%)
Corium to Present at Upcoming Healthcare Conferences

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 11.43 (+6.92%)
Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole

VANCOUVER, BC--(Marketwired - August 24, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing,...

AQS.VN : 0.175 (unch)
AQSZF : 0.1387 (-0.36%)
CORI : 11.43 (+6.92%)
Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole

VANCOUVER, BC--(Marketwired - August 24, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing,...

AQS.VN : 0.175 (unch)
AQSZF : 0.1387 (-0.36%)
CORI : 11.43 (+6.92%)
Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the third quarter ended June 30, 2017 on Thursday, August 3, 2017 after the close of the U.S. financial...

CORI : 11.43 (+6.92%)
Corium International (CORI) Catches Eye: Stock Jumps 11.9%

Corium International, Inc. (CORI) moved big last session, as the company saw its shares rise almost 12% on the day.

AQXP : 11.11 (+2.59%)
CORI : 11.43 (+6.92%)
Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex(TM) Donepezil Transdermal System at Alzheimer's Association International Conference(R) 2017

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 11.43 (+6.92%)
Corium Joins Russell 3000(R) Index

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 11.43 (+6.92%)
Corium to Present at the Jefferies 2017 Global Healthcare Conference

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 11.43 (+6.92%)
Amphastar (AMPH) in Focus: Stock Moves 9.7% Higher

Amphastar Pharmaceuticals (AMPH) was a big mover last session, as the company saw its shares rise almost 10% on the day.

AMPH : 18.38 (+1.27%)
CORI : 11.43 (+6.92%)
Corium Prices Follow-On Offering of Common Stock

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the...

CORI : 11.43 (+6.92%)
AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session

AxoGen, Inc. (AXGN) shares rose a little above 6% in the last trading session.

AXGN : 23.60 (+4.42%)
CORI : 11.43 (+6.92%)
Can The Uptrend Continue for Corium International (CORI)?

Investors certainly have to be happy with Corium International Inc (CORI) and its short term performance

CORI : 11.43 (+6.92%)
Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today reported preliminary...

CORI : 11.43 (+6.92%)
Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited...

CORI : 11.43 (+6.92%)
Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View

Shire plc (SHPG) reported first-quarter 2017 earnings of $3.63 per American Depositary Share (ADS), beating the Zacks Consensus Estimate of $3.22 and up 13.8% from the year-ago quarter figure of $3.19....

SHPG : 147.37 (+1.89%)
INFI : 2.04 (+4.08%)
NVLS : 2.40 (+2.13%)
CORI : 11.43 (+6.92%)
Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards?

We expect Anthem Inc. (ANTM) to beat expectations when it reports first-quarter 2017 results on Apr 26, before the market opens.

BDX : 220.31 (-0.55%)
ANTM : 220.83 (-0.03%)
CORI : 11.43 (+6.92%)
ALGN : 253.89 (-0.40%)
Aimmune Therapeutics Appoints Eric Bjerkholt as Chief Financial Officer

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), today announced the appointment of Eric Bjerkholt as Chief Financial Officer.

AIMT : 34.95 (-0.94%)
JPM : 98.14 (-0.34%)
CORI : 11.43 (+6.92%)

Van Meerten Stock Picks

My 5 Favorite Small Caps
This morning I wanted to find the 5 Small Cap Stocks that had the best returns over the past year but still appeared to have some more room to climb.
SEDG -0.20 , GDOT +0.11 , CTRL -1.36 , ESIO -0.65 , QNST +0.23
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 -0.06% ) this morning are down 0.06% on concern Special Counsel Mueller's criminal investigation between Trump campaign officials and Russia is deepening. Two people familiar with the matter... Read More

Chart of the Day

Chart of the Day

D R Horton (DHI) is the Barchart Chart of the Day.  The home builder has a Trend Spotter buy signal, a Weighted Alpha of 77.13+ and gained 68.46% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed Friday with most contracts 4 – 6 1/2 cents higher, as Dec came back to only lose a half cent on the week. Pre-weekend profit taking gets some of the credit. The CFTC report on Friday showed the spec funds holding a new recor...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart